Author:
Bozymski Kevin M.,Whitten Jessica A.,Blair Mary E.,Overley Ashley M.,Ott Carol A.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health (social science)
Reference44 articles.
1. American Diabetes Association. (2016). Standards of medical care in diabetes—2016. Diabetes Care, 39(Suppl 1), S1–S112.
2. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 272(2), 596–601.
3. Archie, S., Zangeneh-Kazemi, A., & Akhtar-Danesh, N. (2015). First-episode affective psychosis and lipid monitoring: Survival analysis of the first abnormal lipid test. Early Intervention in Psychiatry, 9(6), 507–511.
4. Balotsev, R., Haring, L., Koido, K., Leping, V., Kriisa, K., Zilmer, M., … Vasar, E. (2017). Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12457 .
5. Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., … Schizophrenia Patient Outcomes Research Team (PORT). (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71–93.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献